myrcene has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adem, A; Amir, N; Hellman, B; Islam, AUS; Jayaraj, RL; Nyberg, F; Petroianu, G | 1 |
| Hamilton, TJ; Leigh, S; Szaszkiewicz, J | 1 |
| Adrian, TE; Alkuwaiti, SAA; Almarzooqi, S; Collin, PD; Das, KM; Raj, V; Subramanya, SB; Venkataraman, B | 1 |
3 other study(ies) available for myrcene and Disease Models, Animal
| Article | Year |
|---|---|
Myrcene Attenuates Renal Inflammation and Oxidative Stress in the Adrenalectomized Rat Model.
Topics: Acyclic Monoterpenes; Adrenalectomy; Alkenes; Animals; Anti-Inflammatory Agents; Antioxidants; Body Weight; Catalase; Cell Adhesion Molecules; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Glutathione; Immunologic Factors; Inflammation; Kidney; Lipid Peroxidation; Male; Nitric Oxide Synthase Type II; Oxidative Stress; Rats, Wistar; Superoxide Dismutase | 2020 |
Robust behavioural effects in response to acute, but not repeated, terpene administration in Zebrafish (Danio rerio).
Topics: Acyclic Monoterpenes; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Cannabis; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hypnotics and Sedatives; Limonene; Locomotion; Zebrafish | 2021 |
β-Myrcene Mitigates Colon Inflammation by Inhibiting MAP Kinase and NF-κB Signaling Pathways.
Topics: Animals; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Inflammation; Inflammatory Bowel Diseases; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; Signal Transduction; Tumor Necrosis Factor-alpha | 2022 |